PHARMACEUTICALS – Make In India #ajanta #pharma #kamagra

Posted On May 1 2017 by

#india pharma # SUMMARY Third largest pharmaceuticals market by 2020 in terms of incremental growth. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. India’s filing of Drug Master Files’s (DMF’s) with USFDA as of Dec 2013 is 3411, the highest filed by any country in the world. …


PHARMACEUTICALS – Make In India #pharma #pharmaceutical #company

Posted On Apr 21 2017 by

#india pharma # SUMMARY Third largest pharmaceuticals market by 2020 in terms of incremental growth. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. India’s filing of Drug Master Files’s (DMF’s) with USFDA as of Dec 2013 is 3411, the highest filed by any country in the world. …


PHARMACEUTICALS – Make In India #pharmajob

Posted On Nov 13 2016 by

#india pharma # SUMMARY Third largest pharmaceuticals market by 2020 in terms of incremental growth. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. India’s filing of Drug Master Files’s (DMF’s) with USFDA as of Dec 2013 is 3411, the highest filed by any country in the world. …


PHARMACEUTICALS – Make In India #pharmaceutical #wholesalers

Posted On Nov 6 2016 by

#india pharma # SUMMARY Third largest pharmaceuticals market by 2020 in terms of incremental growth. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. India’s filing of Drug Master Files’s (DMF’s) with USFDA as of Dec 2013 is 3411, the highest filed by any country in the world. …


PHARMACEUTICALS – Make In India #euro #pharma

Posted On Oct 29 2016 by

#india pharma # SUMMARY Third largest pharmaceuticals market by 2020 in terms of incremental growth. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. India’s filing of Drug Master Files’s (DMF’s) with USFDA as of Dec 2013 is 3411, the highest filed by any country in the world. …


PHARMACEUTICALS – Make In India

Posted On Sep 29 2016 by

#india pharma # SUMMARY Third largest pharmaceuticals market by 2020 in terms of incremental growth. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. India’s filing of Drug Master Files’s (DMF’s) with USFDA as of Dec 2013 is 3411, the highest filed by any country in the world. …


PHARMACEUTICALS – Make In India

Posted On Sep 20 2016 by

#india pharma # SUMMARY Third largest pharmaceuticals market by 2020 in terms of incremental growth. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. India’s filing of Drug Master Files’s (DMF’s) with USFDA as of Dec 2013 is 3411, the highest filed by any country in the world. …